NCT00488202

Brief Summary

Women with Advanced Ovarian Cancer (AOC) suffer from severe sexual side effects from treatment. The prevalence of the sexual issues is not known. The degree to which these sexual side effects is affected by treatment is also not known, as the literature in this area focuses on post-treatment analysis. Specific Aim #1 (Quantitative Phase): To determine the prevalence and types of sexual difficulties using self-report questionnaires in women about to receive treatment for Stage III or IV Ovarian Cancer at the BCCA and over time, and to correlate these symptoms with degree of cancer symptoms, well-being, depressive symptoms, and relationship satisfaction

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2007

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2007

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 18, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 20, 2007

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2011

Completed
Last Updated

June 1, 2017

Status Verified

May 1, 2017

Enrollment Period

4.3 years

First QC Date

June 18, 2007

Last Update Submit

May 30, 2017

Conditions

Ovarian CancerSexual Function

Keywords

Advanced Ovarian CancerSexual Function

Eligibility Criteria

Age19 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

women diagnosed with advanced ovarian cancer

You may qualify if:

  • Women with Advanced Ovarian Cancer (AOC) who have not received treatment yet, but who are seeking treatment at the BC Cancer Agency.
  • Women must be able to understand English enough to fill out the questionnaire packages.
  • Mastery of written English is required. No translation services will be available for this study.

You may not qualify if:

  • Anyone without an AOC diagnosis, who are not seeking treatment at BCCA, or who cannot understand enough English to complete the questionnaires will be excluded.
  • Those who do not have a mastery of written English are excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

UBC Sexual Health Lab, Vancouver Hospital

Vancouver, British Columbia, V5M 1M9, Canada

Location

UBC Sexual Health Lab

Vancouver, British Columbia, V5Z 1M9, Canada

Location

MeSH Terms

Conditions

Ovarian Neoplasms

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Neoplasms, FemaleUrogenital NeoplasmsGenital DiseasesEndocrine System DiseasesGonadal Disorders

Study Officials

  • Lori A Brotto, PhD

    UBC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 18, 2007

First Posted

June 20, 2007

Study Start

May 1, 2007

Primary Completion

August 1, 2011

Study Completion

August 1, 2011

Last Updated

June 1, 2017

Record last verified: 2017-05

Locations

CA(2)